Modern GERD treatment: Feasibility of minimally invasive esophageal sphincter augmentation

Anticancer Research

Volumn 34, Issue 5, 2014, Pages 2341-2348

  Schwameis, Katrin ^a   Schwameis, Michael ^a   Zörner, Barbara ^a   Lenglinger, Johannes ^a   Asari, Reza ^a   Riegler, Franz Martin ^a   Schoppmann, Sebastian Friedrich ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Esophageal sphincter; GERD; Laparoscopy; LINX ; Reflux

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGED; ANTI REFLUX IMPLANT; ANTIREFLUX OPERATION; ARTICLE; BLOATING; CLINICAL ARTICLE; DISEASE SEVERITY; DYSPHAGIA; ESOPHAGUS MOTILITY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LAPAROSCOPIC MAGNETIC ESOPHAGUS SPHINCTER AUGMENTATION; LAPAROSCOPIC SURGERY; LOWER ESOPHAGUS SPHINCTER; MALE; MINIMALLY INVASIVE SURGERY; ODYNOPHAGIA; OPERATION DURATION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; SLEEP DISORDER; SWALLOWING; ABDOMINAL SURGERY; CLINICAL TRIAL; EQUIPMENT; FEASIBILITY STUDY; GERD; LAPAROSCOPY; LINX™; METHODOLOGY; MIDDLE AGED; PROSTHESES AND ORTHOSES; REFLUX; TREATMENT OUTCOME; YOUNG ADULT;

ESOPHAGEAL SPHINCTER; GERD; LAPAROSCOPY; LINX™; REFLUX;

ADULT; AGED; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ESOPHAGEAL SPHINCTER, LOWER; FEASIBILITY STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESES AND IMPLANTS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901500715     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. McCann S, Grant AM, Krukowski ZH and Bruce J: Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane database of systematic reviews: CD003243, 2010.
2. Wu P, Zhao XH, Ai ZS, Sun HH, Chen Y, Jiang YX, Tong YL and Xu SC: Dietary intake and risk for reflux esophagitis: a case-control study. Gastroenterol Res Pract: 691026, p9, 2013.
3. Cook MB, Shaheen NJ, Anderson LA, Giffen C, Chow WH, Vaughan TL, Whiteman DC and Corley DA: Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology 142: 744-753, 2012.
4. Chandrasoma P, Wijetunge S, Ma Y, Demeester S, Hagen J and Demeester T: The dilated distal esophagus: A new entity that is the pathologic basis of early gastroesophageal reflux disease. Am J Surg Pathol 35: 1873-1881, 2011.
5. Ganz RA, Peters JH, Horgan S, Bemelman WA, Dunst CM, Edmundowicz SA, Lipham JC, Luketich JD, Melvin WS, Oelschlager BK, Schlack-Haerer SC, Smith CD, Smith CC, Dunn D and Taiganides PA: Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med 368: 719-27, 2013.
6. Kastelein F, Spaander MC, Steyerberg EW, Biermann K, Valkhoff VE, Kuipers EJ, Bruno MJ; ProBar Study Group. Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus. Clin Gastroenterol Hepatol 11: 382-388, 2013.
7. Miyashita T, Shah FA, Harmon JW, Marti GP, Matsui D, Okamoto K, Makino I, Hayashi H, Oyama K, Nakagawara H, Tajima H, Fujita H, Takamura H, Murakami M, Ninomiya I, Kitagawa H, Fushida S, Fujimura T and Ohta T: Do proton pump inhibitors protect against cancer progression in GERD? Surg Today 43: 831-837, 2012.
8. Nasr AO, Dillon MF, Conlon S, Downey P, Chen G, Ireland A, Leen E, Bouchier-Hayes D and Walsh TN: Acid suppression increases rates of Barrett's esophagus and esophageal injury in the presence of duodenal reflux. Surgery 151: 382-390, 2012.
9. Finks JF, Wei Y and Birkmeyer JD: The rise and fall of antireflux surgery in the United States. Surgical endoscopy 20: 1698-1701, 2006.
10. Wang YR, Dempsey DT and and Richter JE: Trends and perioperative outcomes of inpatient antireflux surgery in the United States, 1993-2006. Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus/ISDE 24: 215-223, 2011.
11. Bonavina L, Saino GI, Bona D, Lipham J, Ganz RA, Dunn D and DeMeester T: Magnetic augmentation of the lower esophageal sphincter: Results of a feasibility clinical trial. J Gastroint Surg 12: 2133-2140, 2008.
12. Bonavina L, DeMeester T, Fockens P, Dunn D, Saino G, Bona D, Lipham J, Bemelman W and Ganz RA: Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one-And 2-year results of a feasibility trial. Ann Surg 252: 857-862, 2010.
13. Smith K: GERD. Feeling the pull: a new device for sphincter augmentation. Nat Rev Gastroenterol Hepatol 10: 198, 2013.
14. Ganz RA, Gostout CJ, Grudem J, Swanson W, Berg T and DeMeester TR: Use of a magnetic sphincter for the treatment of GERD: a feasibility study. Gastrointest Endosc 67: 287-294, 2008.
15. Mesteri I, Beller L, Fischer-See S, Schoppmann S, Lenglinger J, Wrba F, Riegler M and Zacherl J: Radiofrequency ablation of Barrett's esophagus and early cancer within the background of the pathophysiology of the disease. Eur Surg 44: 366-382, 2012.
16. Mesteri I, Lenglinger J, Beller L, Fischer-See S, Schoppmann SF, Wrba F, Riegler FM and Zacherl J: Assessment of columnar-lined esophagus in controls and patients with gastroesophageal reflux disease with and without proton-pump inhibitor therapy. Eur Surg 44: 304-313, 2012.
17. Velanovich V: Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 2: 141-145, 1998.
18. ® reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc 26: 2944-2949, 2012.
19. Scheurlen M: Long-term use of proton pump inhibitors: who needs prophylaxis?. Internist 54: 366-372, 2013 (in German).
20. de Jager CP, Wever PC, Gemen EF, van Oijen MG, van Gageldonk-Lafeber AB, Siersema PD, Kusters GC and Laheij RJ: Proton pump inhibitor therapy predisposes to community-Acquired Streptococcus pneumoniae pneumonia. Aliment Pharmacol Ther 36: 941-949, 2012.
21. Jena AB, Sun E and Goldman DP: Confounding in the association of proton pump inhibitor use with risk of community-Acquired pneumonia. J Gen Intern Med 28: 223-230, 2013.
22. Triadafilopoulos G, Roorda A and Akiyama J: Indications and safety of proton pump inhibitor drug use in patients with cancer. Expert Opin Drug Saf 5: 659-672, 2013.